Melodiol Global Health Limited Stock

Equities

ME1

AU0000282840

Pharmaceuticals

Market Closed - Australian S.E. 01:46:38 2024-04-19 am EDT 5-day change 1st Jan Change
0.0045 AUD +12.50% Intraday chart for Melodiol Global Health Limited -10.00% -88.75%
Sales 2022 8.92M 5.72M Sales 2023 18.92M 12.14M Capitalization 9.46M 6.07M
Net income 2022 -32M -20.53M Net income 2023 -52M -33.37M EV / Sales 2022 4.71 x
Net Debt 2022 5.28M 3.39M Net Debt 2023 8.95M 5.75M EV / Sales 2023 0.97 x
P/E ratio 2022
-0.89 x
P/E ratio 2023
-0.11 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 71.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day+12.50%
1 week+12.50%
Current month-10.00%
3 months-77.50%
6 months-96.54%
Current year-88.75%
More quotes
1 week
0.00
Extreme 0.004
0.01
1 month
0.00
Extreme 0.004
0.01
Current year
0.00
Extreme 0.004
0.04
1 year
0.00
Extreme 0.004
0.44
3 years
0.00
Extreme 0.004
4.40
5 years
0.00
Extreme 0.004
11.50
10 years
0.00
Extreme 0.004
33.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-09-16
Director of Finance/CFO - 17-11-20
Chief Operating Officer 38 18-06-13
Members of the board TitleAgeSince
Director/Board Member 57 22-01-16
Director/Board Member 71 22-11-29
Founder - 15-11-19
More insiders
Date Price Change Volume
24-04-19 0.0045 +12.50% 48 653
24-04-18 0.004 0.00% 2,797,808
24-04-17 0.004 0.00% 646,840
24-04-16 0.004 -20.00% 15,784,940
24-04-15 0.005 +25.00% 6,708,200

Delayed Quote Australian S.E., April 19, 2024 at 01:46 am EDT

More quotes
Melodiol Global Health Limited, formerly Creso Pharma Limited, is an Australia-based cannabis company. The Company is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC). Its product is offered under various brands, including Green Goo, Southern Butter, Good Goo, Ritual, impactive and cannaQIX, among others. It cultivates and harvests cannabis plants through its subsidiary, Mernova Medicinal Inc. and supplies cannabis retail products throughout Canada. Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc., it is also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
Calendar
More about the company